Fei Wang

8.4k citations
291 papers · 6.8k indexed · 1 hit paper · h-index 44

Fei Wang

278 papers receiving 6.7k citations

Hit Papers

Immunogenic Cell Death Augmented by Manganese Zinc Sulfid...174202220262023202450100150

Peers

Fei Wang
Comparison fields: 5 of 152
  • Biomaterials 1.2k
  • Biotechnology 502
  • Biomedical Engineering 2.3k
  • Biochemistry 233
  • Organic Chemistry 1.1k
Replace Hong Wu with:
Hong Wu China
Hao Liang China
Changzhu Li China
Qipeng Yuan China
Seyed Abbas Shojaosadati Iran
Rosfarizan Mohamad Malaysia
Xiangzhao Mao China
Adalberto Pessoa Brazil
Zhimin He China
Shaoyun Wang China
Fei Wang relative to Hong Wu China Hong Wu's profile →
Citations per field
00.5×1.5×2.0×
Hong Wu · 1×
Citations per year

Countries citing papers authored by Fei Wang

Since Specialization
Citations

This map shows the geographic impact of Fei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Wang more than expected).

Fields of papers citing papers by Fei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Wang. The network helps show where Fei Wang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fei Wang Line = papers co-authored together Fei Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20244
3 20241
4 20248
5 20242
6 202436
7 20240
8 202315
9 20232
10 20239
11 202321
12 202318
13 20235
14 202314
15 20218
16 202025
17 202019
18 201913
19 201930
20 201834

About Fei Wang

Fei Wang is a scholar working on Biomaterials, Biochemistry, Biotechnology, Biomedical Engineering and Organic Chemistry, having authored 291 papers that have together received 6.8k indexed citations. Recurring topics across this work include Microbial Metabolic Engineering and Bioproduction (45 papers), Enzyme Catalysis and Immobilization (39 papers), Nanoparticle-Based Drug Delivery (33 papers), Biofuel production and bioconversion (30 papers), Sulfur-Based Synthesis Techniques (28 papers), Plant biochemistry and biosynthesis (27 papers), Nanoplatforms for cancer theranostics (22 papers) and Catalysis for Biomass Conversion (18 papers). The work is most often cited by research in Biomaterials (1.2k citations), Biotechnology (502 citations), Biomedical Engineering (2.3k citations), Biochemistry (233 citations) and Organic Chemistry (1.1k citations). Fei Wang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Xun Li, Yu Zhang, Yixin Dong, Chaoqun You, Like Ning, Shaobing Peng, Shenlin Huang, Shun‐Yi Wang, Hao Shi and Chanjuan Xi. Their work appears in journals such as ACS Sustainable Chemistry & Engineering, Journal of Agricultural and Food Chemistry, Organic Letters, Industrial Crops and Products and BioResources.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026